Company / Working Capital
Ensysce Biosciences, Inc. Working Capital History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$2.7M
FY2025
5-year range
-$4.2M / $3.1M
FY2022-FY2025
Trend
-14.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$1M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025.
Improved from -$1M to $3M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital decreased 14.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7M | -14.7% |
| FY2024 | $3.1M | +400.5% |
| FY2023 | -$1.0M | +74.9% |
| FY2022 | -$4.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026